Cue Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Warren Lucinda
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Warren Lucinda
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Levisetti Matteo
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Suri Anish
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Fox Michael J
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sandercock Colin
Cue Biopharma | 3: Initial statement of beneficial ownership of securities-Director Fox Michael J
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Millar Kerri-Ann
Cue Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer PASSERI DANIEL R
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Millar Kerri-Ann
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Suri Anish
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sandercock Colin
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Levisetti Matteo
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Levisetti Matteo
Cue Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(4.98%)
Cue Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.2%)
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director DRISCOLL FREDERICK W
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Garzone Pamela
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Kiener Peter A
No Data